₹332.2
▼ -11.02 -3.21%
17 Jul 2026
NSE Listed · Pharmaceuticals
ASM 1Wanbury Limited (WANBURY)
Volume: 4,75,298Avg Vol 1W: 7,36,012Avg Vol 1M: 6,02,02252W Range:₹161.5₹358.85
Key Ratios
Checked just nowMarket Cap₹1,161 Cr
Current Price₹332.2
Previous Close₹343.22
High / Low (52w)₹358.85 / ₹161.5
Volume4,75,298
Avg Vol (1W)7,36,012
Avg Vol (1M)6,02,022
Stock P/E27.01
Book Value₹22.16
Dividend Yield0%
ROE51.51%
ROA10.39%
Revenue (TTM)—
Revenue Growth3.77%
Profit Margin6.83%
Total Debt₹160 Cr
Shares Outstanding3 Cr
Face Value₹10
EPS (TTM)₹12.3
P/B14.99
Debt / Equity3.38
50 DMA₹288.59
200 DMA₹263.89
Day change-3.21%
SurveillanceASM 1 (as of 2026-07-17)
Price Chart
₹332.2▲ 43.81% · 1Y
2025-11-242026-07-17
20-day avg volume: 6.5L shares
Pros
- Healthy return on equity of 51.5%.
- Company is almost debt-free.
Quarterly Results
| Metric | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹144 Cr | ₹146 Cr | ₹139 Cr | ₹131 Cr | ₹161 Cr | ₹133 Cr | ₹172 Cr | ₹163 Cr |
| EBITDA | ₹15 Cr | ₹19 Cr | ₹16 Cr | ₹9 Cr | ₹18 Cr | ₹11 Cr | ₹28 Cr | ₹21 Cr |
| Net Profit | ₹7 Cr | ₹10 Cr | ₹34 Cr | ₹1 Cr | ₹8 Cr | ₹1 Cr | ₹20 Cr | ₹13 Cr |
| EPS | — | — | — | — | — | — | — | — |
Profit & Loss (Annual)
| Metric | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹448 Cr | ₹401 Cr | ₹369 Cr | ₹395 Cr | ₹513 Cr | ₹501 Cr | ₹579 Cr | ₹603 Cr |
| EBITDA | ₹-2 Cr | ₹15 Cr | ₹15 Cr | ₹11 Cr | ₹25 Cr | ₹12 Cr | ₹60 Cr | ₹67 Cr |
| Net Profit | ₹-32 Cr | ₹-25 Cr | ₹64 Cr | ₹-13 Cr | ₹81 Cr | ₹-10 Cr | ₹56 Cr | ₹31 Cr |
| EPS | -13.49 | -10.48 | 26.9 | -5.04 | 25.21 | -3.18 | 16.89 | 8.98 |
Balance Sheet
| Metric | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | ₹273 Cr | ₹286 Cr | ₹279 Cr | ₹289 Cr | ₹353 Cr | ₹304 Cr | ₹343 Cr | ₹414 Cr |
| Total Liabilities | ₹457 Cr | ₹495 Cr | ₹422 Cr | ₹445 Cr | ₹376 Cr | ₹336 Cr | ₹316 Cr | ₹355 Cr |
| Equity | ₹-185 Cr | ₹-209 Cr | ₹-143 Cr | ₹-156 Cr | ₹-23 Cr | ₹-33 Cr | ₹28 Cr | ₹59 Cr |
| Total Debt | — | — | — | — | — | — | — | — |
Cash Flow
| Metric | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating | ₹33 Cr | ₹30 Cr | ₹44 Cr | ₹18 Cr | ₹41 Cr | ₹20 Cr | ₹4 Cr | ₹26 Cr |
| Investing | ₹-1 Cr | ₹-3 Cr | ₹64 Cr | ₹8 Cr | ₹1 Cr | ₹-9 Cr | ₹-17 Cr | ₹-51 Cr |
| Financing | ₹-33 Cr | ₹-27 Cr | ₹-108 Cr | ₹-17 Cr | ₹-29 Cr | ₹-32 Cr | ₹15 Cr | ₹26 Cr |
| Free Cash Flow | ₹31 Cr | ₹25 Cr | ₹36 Cr | ₹13 Cr | ₹31 Cr | ₹7 Cr | ₹-13 Cr | ₹-23 Cr |
Shareholding
Promoter 43.02% Institutions 0.59% Public 56.39%
Efficiency & Working Capital
ROCE28%
Interest Coverage1.9
Dividend Payout—
Debtor Days70 d
Inventory Days23 d
Payable Days84 d
Cash Conversion Cycle8 d
Working Capital Days92 d
Shareholding Details
As of 2026-03-31
Promoter43%
FII0.6%
DII0%
Institutions0.6%
Public56.4%
Promoter Pledge86.7%
No. of Shareholders16,732
Shareholding Pattern
Quarterly — figures in %. Latest 12 quarters.
| Period | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 39.8% | 39.8% | 39.8% | 39.8% | 39.8% | 39.8% | 39.8% | 39.8% | 39.6% | 43.1% | 43.1% | 43% |
| FIIs | 0% | 0% | 0% | 0.2% | 0.2% | 1% | 0.8% | 1.6% | 1.6% | 0.8% | 0.7% | 0.6% |
| DIIs | 0.1% | 0% | 0.1% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Public | 60% | 60.2% | 60.1% | 60% | 60% | 59.2% | 59.4% | 58.7% | 58.8% | 56.1% | 56.2% | 56.4% |
| Promoter Pledge | 76.7% | 76.7% | 76.7% | 71.1% | 76.7% | 76.7% | 76.7% | 76.7% | 76.7% | 86.7% | 86.7% | 86.7% |
| No. of Shareholders | 11,741 | 11,634 | 11,616 | 13,087 | 14,400 | 17,199 | 17,999 | 17,889 | 17,894 | 17,717 | 17,261 | 16,732 |
Returns History (ROE / ROCE / ROA)
| Period | ROE | ROCE | ROA | P/E |
|---|---|---|---|---|
| 202503 | — | — | — | — |
Major Shareholders (>1%)
| Name | Category | Stake | Shares |
|---|---|---|---|
| Expert Chemicals (india) Pvt Ltd | Shareholding of Promoter and Promoter Group | 34.4% | 1.20 Cr |
| Kingsbury Investments Inc | Shareholding of Promoter and Promoter Group | 8.7% | 30,24,000 |
| Suresh Bhatia | Public Shareholding | 3.1% | 10,87,795 |
| Authum Investment And Infrastructure Limited | Public Shareholding | 2.1% | 7,22,865 |
| Zaki Abbas Nasser | Public Shareholding | 1.7% | 5,75,000 |
| Sharmin Nasser | Public Shareholding | 1.4% | 4,85,000 |
| Basava Sankararao Kolli | Public Shareholding | 1.1% | 3,67,999 |
Promoter Pledges
| Holder | Pledged Shares | % of Holding | As of |
|---|---|---|---|
| Expert Chemicals (india) Pvt Ltd | 1.00 Cr | 83.3% | 2026-03-31 |
| Kingsbury Investments Inc | 30,24,000 | 100% | 2026-03-31 |
| Zaki Abbas Nasser | 0 | 0% | 2026-03-31 |
| Sharmin Nasser | 0 | 0% | 2026-03-31 |
| Basava Sankararao Kolli | 0 | 0% | 2026-03-31 |
| Suresh Bhatia | 0 | 0% | 2026-03-31 |
| Authum Investment And Infrastructure Limited | 0 | 0% | 2026-03-31 |
| Expert Chemicals (india) Pvt Ltd | 1.00 Cr | 83.3% | 2025-12-31 |
| Kingsbury Investments Inc | 30,24,000 | 100% | 2025-12-31 |
| Sharmin Nasser | 0 | 0% | 2025-12-31 |
| Suresh Bhatia | 0 | 0% | 2025-12-31 |
| Authum Investment And Infrastructure Limited | 0 | 0% | 2025-12-31 |
Board of Directors
| Name | Designation | Year |
|---|---|---|
| K Chandran | E D & Wholetime Director | 2025 |
| Mohan Kumar Rayana | WTD & Executive Director | 2025 |
| Anupam Vaidya | Independent Non Exe. Director | 2025 |
| Mridul Sumanlal Mehta | Independent Non Exe. Director | 2025 |
| MANOJKUMAR KHUBCHAND GURSAHANI | Independent Non Exe. Director | 2025 |
| Pallavur Sankar Dass Vaidyanathan | Independent Non Exe. Director | 2025 |
| Jitendra J Gandhi | Company Sec. & Compli. Officer | 2025 |
Segments — Product
| Segment | Revenue | Share |
|---|---|---|
| Pharmaceutical | ₹0 Cr | — |
Segments — Geography
| Region | Revenue | Share |
|---|---|---|
| India | ₹204 Cr | 40.3% |
| Outside India | ₹303 Cr | 59.7% |
Capital Structure (₹ Cr)
| Year | Face Value | Authorised | Issued | Paid-up |
|---|---|---|---|---|
| 2025 | ₹10 | 50 | 33 | 33 |
Related-Party Transactions (₹ Cr)
| Year | Subsidiaries | Associates | JV | KMP | Others | Total |
|---|---|---|---|---|---|---|
| 2025 | 3 | 0 | 0 | 3 | 0 | — |
| 2025 | 3 | 0 | 0 | 3 | 0 | 6 |
| 2025 | 3 | 0 | 0 | 3 | 0 | 6 |
Insider / Designated-Person Trades
4 recent disclosure(s)
SBICAP Trustee Company LimitedRevoke · 91,72,561
SBICAP Trustee Cumpany LimitedPledge · 85,000
SBICAP trustee Company LimitedPledge · 7,40,743
SBICAP Trustee Company LimitedPledge · 59,25,231
Substantial Acquisitions (SAST)
5 disclosure(s)
Release of Shares25/07/2025 · —
Pledge15/05/2024 · —
Pledge08/04/2024 · —
Pref. Allotment21/03/2024 · —
Market27/01/2022 · 17,50,000
Company Information
🌐 www.wanbury.com ↗
📍 BSEL Tech Park B-Wing 10th Flr, Sector 30 A Opp Vashi Rly Stat, Navi Mumbai, Maharashtra, 400703
Technical AnalysisPremium
Technical analysis (Premium)
Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.
More stocks
Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search